Editas Medicine Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 11 of 11 Posts
Wall Street's Top Stories For Christmas Weekend
Article By: The Fly Sunday, December 23, 2018 3:55 PM EDT
Stocks end week on down note amid concerns of government shutdown and company updates on Nike, Altira, Perrigo, JD, NetEase, Air Transport Service, Amazon, Editas Medicine and CalAmp.
In this article: JD, MO, NKE, AMZN, ATSG, CAMP, NTES, PRGO, EDIT
Read
CRISPR Stocks Rise After Chinese Researcher Claims First Gene-Edited Babies
Article By: The Fly Monday, November 26, 2018 1:47 PM EDT
Shares of Crispr Therapeutics, Editas Medicine and Intellia Therapeutics are on the rise after a Chinese researcher claimed that he helped make the world's first genetically edited babies.
In this article: CRSP, EDIT, NTLA Also: SGMO
Read
Winners Of Q1 Earnings: 5 Best ETF Charts
Article By: Sweta Killa Sunday, May 27, 2018 4:01 PM EDT
several equity ETFs have impressed with their performances and generated handsome returns over the trailing one month even after being hit by the trade worries and geopolitical tensions. Here are five ETFs that buoyed up on robust earnings results.
In this article: PTH, SPY, PSCE, GAMR, ARKK, ILMN, SSYS, TSLA, EDIT, NTLA, MKSI, FTXL
Read
Three ‘Strong Buy’ Biotechs To Tap Now
Article By: TipRanks Wednesday, May 16, 2018 9:58 AM EDT
Which biotechs are paving the way to precisely repair the genes in the DNA?
In this article: VRTX, EDIT, CRSP
Read
E Ford Model T And Personalized Medicine
Article By: Ketan Desai Monday, December 11, 2017 10:35 AM EDT
While technology marches on, the economics of personalized medicines just don’t add up. Will they be like costly trinkets being displayed in a museum that we can watch at a distance but not own?
In this article: JUNO, KITE, EDIT
Read
Editas Medicine, Inc., Announces Pricing Of $50 Million Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Wednesday, December 6, 2017 12:25 PM EDT
Editas Medicine, Inc., a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common stock.
In this article: EDIT
Read
HH Small Cap Biotech Stocks Soar: How Long Will Rotation Last?
Article By: Rod Raynovich Thursday, October 5, 2017 9:06 PM EDT
Speculation in small cap biotech picks up, a boon for diligent traders. ETF buying is driving all small cap and microcap stocks higher.
In this article: AVEO, ZIOP, IJS, IWC, IWM, XBI, FPRX, RXDX, XNCR, CNCR, EDIT
Read
Biotech Rally Moving Toward April Highs: ASCO And M&A Provides Underlying Support
Article By: Rod Raynovich Wednesday, June 1, 2016 12:03 AM EDT
Biotech stocks are pretty solid over two weeks probably anticipating ASCO news and helped by more M&A news. Since hitting a recent low of $258.90 on May 19 the IBB is up over 8% and 6% over five days to $279.77 yesterday.
In this article: ALNY, ARIA, ARRY, IBB, JAZZ, GILD, XBI, XLV, JUNO, ABBV, KITE, BLUE, CPXX, EDIT
Read
Intellia Jumps On CRISPR IPO Bandwagon
Article By: IPO Candy Thursday, May 5, 2016 4:10 PM EDT
Editas (EDIT) proved that investor interest in its area is high. Intellia is another high-quality player. These are really call options “worth” about $1B each right now.
In this article: NTLA, EDIT
Read
Healthcare Stocks Lead On A Lackluster Day
Article By: Rod Raynovich Monday, April 4, 2016 8:30 PM EDT
Lagging healthcare and biotech stocks found buyers today. The healthcare SPDR ETF was up 1.05% to $69.38 as investors were probably seeking dividends and safety with fears about pricing tempered.
In this article: BMY, EW, RHHBY, ACAD, ALNY, ALXN, ANAC, IBB, GILD, NBIX, VRTX, ZIOP, XBI, XLV, ESPR, ABBV, KITE, BLUE, EDIT
Read
A CRISPR View Of Editas Medicine Inc.
Article By: IPO Candy Monday, February 8, 2016 5:15 PM EDT
Editas completed their IPO this week in a difficult market and is now the first "pure play" on CRISPR. As we evaluate Editas as an investment opportunity we'll cover some of the advantages CRISPR offers in terms of drug development.
In this article: EDIT Also: SGMO
Read
1 to 11 of 11 Posts